Breaking News
Investing Pro 0
New Year’s SALE: Up to 40% OFF InvestingPro+ CLAIM OFFER
Close

Vectura Group PLC (VEC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Vectura historical data, for real-time data please try another search
164.80 0.00    0.00%
18/10 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 164.60 / 165.00
  • Day's Range: 164.80 - 165.00
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BKM2MW97 
SEDOL:  BKM2MW9
Vectura 164.80 0.00 0.00%

Vectura Group PLC Company Profile

 
Read the Vectura company profile to learn more about the business and the management team. View employee data, company address and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Vectura Group plc engages in the development of pharmaceutical therapies for the treatment of airways-related diseases. Vectura Group plc was formerly known as Vectura Limited and changed its name to Vectura Group plc in June 2004. The company was incorporated in 1997 and is based in Wiltshire, United Kingdom. As of October 19, 2021, Vectura Group plc operates as a subsidiary of PMI Global Services, Inc.

Contact Information

Phone 44 12 4966 7700
Fax 44 12 4966 7701
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VEC Comments

Write your thoughts about Vectura Group PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Hamilton
Mike Hamilton May 26, 2021 12:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
£958 million takeover yesterday by Carlyle Group.
yash kanabar
yash kanabar Nov 19, 2020 16:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone know why the share popped 13% today?
Mark Hopkin
Mark Hopkin Nov 19, 2020 16:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Glaxo denied appeal.
Mark Hopkin
Mark Hopkin Nov 19, 2020 16:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Glaxo denied appeal.
Arvinder Mann
ARVI Oct 30, 2020 8:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email